Skip to main content

Table 3 Clinical events bleeding, VTE or death

From: Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients

 

Number of patients

(number of events or %)

COVID (n = 30)

(number of events or %)

Non-COVID (n = 32)

(number of events or %)

Bleeding

Total

14 (20)

9 (12)

5 (8)

Major

3 (6)

1 (1)

2 (5)

CRNM

5 (6)

3 (4)

2 (2)

Minor

6 (8)

5 (7)

1 (1)

Venous TromboEmbolism (VTE)

Total (%)

7 (11%)

7 (23%)

0 (0%)

DVT

1

1

0

PE

6

6

0

Death

Total (%)

12 (19%)

5 (17%)

7 (22%)

  1. COVID = Corona Virus Infectious Disease, CRNM = Clinically Relevant Non-Major bleeding, DVT = Deep Vein Thrombosis, PE = Pulmonary Embolism, VTE = Venous TromboEmbolism
  2. Bleeding event or VTE during IC stay, death during hospital stay